What is the role of Immunohistochemistry (IHC) in a comprehensive diagnostic panel for a patient suspected of having multiple myeloma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board

Educational purpose only • Exercise caution as content is pending human review

Article Review Status

Submitted

Under Review

Approved

Last updated: January 21, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

What markers should be used for immunohistochemistry (IHC) on bone marrow biopsy to confirm clonality of plasma cells in myeloma?

Why do I need a lung computed tomography (CT) scan when I just had a positron emission tomography (PET) CT whole body scan that showed no evidence of active multiple myeloma?

What is the appropriate diagnostic workup for a patient with a monoclonal kappa peak?

What is the next step in managing a patient with borderline high total protein, borderline high calcium, and low Mean Corpuscular Volume (MCV), suspected of having multiple myeloma?

What is the next best step prior to initiating chemotherapy in a patient with multiple myeloma?

What alternative medications can be used to treat a patient with Generalized Anxiety Disorder (GAD)?

What is a safe muscle relaxer option for an elderly woman with a solitary kidney and impaired renal function?

What adjustments should be made to the treatment regimen for a patient with type 2 diabetes mellitus (T2DM) and an Hemoglobin A1c (HbA1c) level of 9.6, who is currently taking sitagliptin (Januvia) 50mg daily and Humalog (insulin lispro) 4 units daily, along with a sliding scale insulin regimen?

What is the best course of action for a patient with hypertension (HTN) who is experiencing a bleed while being treated with Telmisartan (Tab telma h)?

What is the best management approach for an 8kg patient with Achondroplasia, SCAP, and Adenoid Tonsillar Hypertrophy, presenting with severe respiratory distress, tachycardia, tachypnea, and hypoxemia, while on ceftriaxone and Paracetamol?

What is the management approach for a patient with high-grade invasive urothelial carcinoma and no lymphovascular involvement?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.